INmune Bio Inc (NASDAQ: INMB) is -68.31% lower on its value in year-to-date trading and has touched a low of $4.32 and a high of $11.64 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INMB stock was last observed hovering at around $5.33 in the last trading session, with the day’s gains setting it 1469994.67%.
Currently trading at $1470000.0, the stock is -66.75% and -68.45% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 32.57 million and changing -56.66% at the moment leaves the stock -65.54% off its SMA200. INMB registered -50.54% loss for a year compared to 6-month gain of -48.55%. The firm has a 50-day simple moving average (SMA 50) of $7.321 and a 200-day simple moving average (SMA200) of $6.7027.
The stock witnessed a -68.61% loss in the last 1 month and extending the period to 3 months gives it a -69.28%, and is -62.86% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 39.18% over the week and 16.31% over the month.
INmune Bio Inc (INMB) has around 22 employees, a market worth around $53.62M and $0.05M in sales. Profit margin for the company is -81592.00%. Distance from 52-week low is -46.53% and -80.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-136.56%).
The EPS is expected to grow by 24.49% this year, but quarterly earnings will post 138.07% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
INmune Bio Inc (INMB) Top Institutional Holders
112.0 institutions hold shares in INmune Bio Inc (INMB), with institutional investors hold 35.74% of the company’s shares. The shares outstanding are 22.93M, and float is at 16.50M with Short Float at 43.98%. Institutions hold 25.66% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.81 million shares valued at $7.17 million. The investor’s holdings represent 4.2103% of the INMB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.63 million shares valued at $5.54 million to account for 3.2542 of the shares outstanding. The other top investors are CVI HOLDINGS, LLC which holds 0.6 million shares representing 3.0888% and valued at over $5.26 million, while PRAETORIAN PR LLC holds 2.512 of the shares totaling 0.48 million with a market value of $4.28 million.
INmune Bio Inc (INMB) Insider Activity
The most recent transaction is an insider purchase by Moss David J, the company’s Chief Financial Officer. SEC filings show that Moss David J bought 10,000 shares of the company’s common stock on Sep 30 ’24 at a price of $5.29 per share for a total of $52868.0. Following the purchase, the insider now owns 1.29 million shares.
INmune Bio Inc disclosed in a document filed with the SEC on Sep 12 ’24 that Tesi Raymond Joseph (President and CEO) bought a total of 15,380 shares of the company’s common stock. The trade occurred on Sep 12 ’24 and was made at $6.38 per share for $98048.0. Following the transaction, the insider now directly holds 1.55 million shares of the INMB stock.
Still, SEC filings show that on Sep 12 ’24, Moss David J (Chief Financial Officer) acquired 7,690 shares at an average price of $6.38 for $49024.0. The insider now directly holds 1,275,869 shares of INmune Bio Inc (INMB).
